Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shalbha Tiwari is active.

Publication


Featured researches published by Shalbha Tiwari.


British Journal of Nutrition | 2013

Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection

Shalbha Tiwari; Daliparthy D. Pratyush; Balram Gupta; Awanindra Dwivedi; Sandeep Chaudhary; Rammohan K. Rayicherla; Sanjeev Kumar Gupta; Surya Kumar Singh

The aim of the present research was to study the prevalence and severity of vitamin D deficiency in patients with diabetic foot infection. Patients were enrolled in two groups: diabetic patients with foot infection (n 125) as cases and diabetic patients without the infection as controls (n 164). Serum 25-hydroxyvitamin D (25(OH)D) was measured by RIA. Data were presented as means and standard deviations unless otherwise indicated and were analysed by SPSS. Results revealed that 25(OH)D (nmol/l) was significantly lower (40·25 (sd 38·35) v. 50·75 (sd 33·00); P < 0·001) in cases than in controls. Vitamin D inadequacy (25(OH)D < 75 nmol/l) was equally common in cases and controls (OR 1·45, 95 % CI 0·8, 3·0; P = 0·32), but cases had a greater risk of vitamin D deficiency (25(OH)D < 50 nmol/l) than controls (OR 1·8, 95 % CI 1·1, 3·0; P = 0·02). Risk of severe vitamin D deficiency (25(OH)D < 25 nmol/l) was significantly higher in cases than in controls (OR 4·0, 95 % CI 2·4, 6·9; P < 0·0001). Age, duration of diabetes and HbA1c were significantly higher in cases than in controls and therefore adjusted to nullify the effect of these variables, if any, on study outcome. The study concluded that vitamin D deficiency was more prevalent and severe in patients with diabetic foot infection. This study opens up the issue of recognising severe vitamin D deficiency (< 25 nmol/l) as a possible risk factor for diabetic foot infections and the need for vitamin D supplementation in such patients for a better clinical outcome. This could be substantiated by similar data from future studies.


Gene | 2012

A new approach to touch down method using betaine as co-solvent for increased specificity and intensity of GC rich gene amplification.

Daliparthy D. Pratyush; Shalbha Tiwari; Ashok Kumar; Surya Kumar Singh

Tissue specific genes that contain high GC segments are difficult to amplify by standard PCR. We report an improved method for successful amplification of gene segment that has >70% GC base pairs. This new method of touch down PCR differed by having an initial annealing temperature (Ta) 1.5°C below the primers melting temperature that descended 0.2°C per cycle for 20 cycles and continued thereafter at fixed Ta for next 15 cycles. Different co-solvents were tested with this method to improve the result and betaine proved better than the other co-solvents. This new method is economical, fast and specific in amplifying GC rich region of other genes also.


Indian Journal of Endocrinology and Metabolism | 2012

Waist circumference cutoff and its importance for diagnosis of metabolic syndrome in Asian Indians: A preliminary study

Daliparthy D. Pratyush; Shalbha Tiwari; Saurabh Singh; Surya Kumar Singh

Background: There is inconsistency in accepting waist circumference (WC) as mandatory and also regarding its significance for diagnosis of metabolic syndrome (MetS) for different populations. Aim: To study the association of individual parameters of MetS with WC cutoffs suitable for South Asian Indians. Materials and Methods: From an ongoing hospital-based study on MetS as per the criteria of diagnosis of modified NCEP ATP III, 713 subjects having a minimum three of the four parameters, i.e., dyslipidemia [low high density lipoprotein (HDL), high triglycerides], dysglycemia and hypertension, without regard to cutoffs of WC, were included in the present study. Results: Receiver operator characteristic curve analysis of WC cut-off points for males was 90 cm with a sensitivity and specificity of 71% and 96%, respectively, and for females was 85 cm with a sensitivity and specificity of 86% and 93%, respectively, associated with the risk factors of MetS. Multiple logistic regression analysis for low density lipoprotein (LDL) cholesterol concentration of ≥3.38 mmol/l showed an odds ratio of 5.03 (95% CI = 1.29–19.5) in males and 3.17 (95% CI = 1.14–8.76) in females which was statistically significant (P < 0.02); in addition to higher WC, higher level of triglyceride (P ≤ 0.0001) and lower level of high density lipoprotein cholesterol (P ≤ 0.02) were observed. Conclusion: This study suggests that WC of 90 cm in males and 85 cm in females should be a mandatory criterion of MetS in our subset of population. LDL may be considered one of the components of MetS along with the currently defined WC cutoffs.


Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2016

Risk factors of diabetes in North Indians with metabolic syndrome

Daliparthy D. Pratyush; Shalbha Tiwari; Saurabh Singh; Surya Kumar Singh

AIM Metabolic syndrome progresses to diabetes and determinants of this progression like hyperinsulinemia, hypertriglyceridemia and genetic factors have been speculative. The present study was aimed at quantifying the insulin resistance and influence of family history of diabetes in subjects with metabolic syndrome developing prediabetes and diabetes. METHODS Consecutive subjects attending the endocrine clinic were evaluated for metabolic syndrome as per definition of International Diabetes Federation, 2005. The family history of diabetes in their first degree relatives was ascertained and Homeostasis model assessment of Insulin resistance (HOMA-IR), Homeostasis model assessment for beta cell function (HOMA-B) and Quantitative insulin sensitivity check index (QUICKI) were calculated in 163 subjects enrolled. RESULTS HOMA-IR was higher (p<0.05) but HOMA-B and QUICKI were lower (p<0.0001) in subjects with metabolic syndrome+prediabetes or diabetes compared to metabolic syndrome with normal glucose tolerance. HOMA-B was lower and prevalence of prediabetes and diabetes was higher in metabolic syndrome subjects with family history of diabetes than in those without such family history (p<0.05). CONCLUSIONS subjects with metabolic syndrome having prediabetes and diabetes had more severe insulin resistance than those with metabolic syndrome only. Beta cell dysfunction was remarkable and prevalence of prediabetes was high in metabolic syndrome subjects with family history of diabetes. Both the severity of the insulin resistance and family history of diabetes are therefore proposed to be determinants of diminished Beta cell function leading to diabetes in metabolic syndrome.


Indian Journal of Endocrinology and Metabolism | 2013

Vitamin D status of patients with type 2 diabetes and sputum positive pulmonary tuberculosis

Sandeep Chaudhary; Anubhav Thukral; Shalbha Tiwari; Daliparthy D. Pratyush; Surya Kumar Singh

Introduction: Vitamin D deficiency is expected to be higher in patients with diabetes and pulmonary tuberculosis (TB). Studies estimating prevalence in the subset of patients with both diabetes and pulmonary TB are scarce. Materials and Methods: A total of 155 subjects were recruited; 46 patients with type 2 diabetes, 39 non-diabetic healthy controls, 30 patients of pulmonary TB and 40 patients with both pulmonary TB and type 2 diabetes. Vitamin D level (25 OH vitamin D) levels were done for all the 4 groups. Results: Mean vitamin D levels were not different between groups with TB, diabetes mellitus or combination of both, but the prevalence of severe vitamin D deficiency was higher in the group with both diabetes and TB (45%) as compared with the group with only TB (26.66%) and diabetes (17.39%) and healthy controls (7.69%). Conclusion: The prevalence of patients with severe vitamin D deficiency is higher in patients with dual affection of TB and diabetes mellitus as compared with either disorder alone implying that patients with type 2 diabetes with the most severe vitamin D deficiency are the one of the most predisposed to pulmonary TB.


Indian Journal of Endocrinology and Metabolism | 2015

Association between serum albumin and glycated hemoglobin in Asian Indian subjects

Shalbha Tiwari; Manish M Bothale; Imtiaz Hasan; Mahesh J. Kulkarni; Mehmood G Sayyad; Rita Basu; Ananda Basu; Ambika Gopalakrishnan Unnikrishnan

Background: Protein glycation plays a significant role in diabetic complications. Glycated hemoglobin (HbA1c) is a known predictor of diabetes and its complications. Albumin, found to be profoundly glycated in diabetes, and its level could regulate plasma protein as well as hemoglobin glycation. Aim: We aimed to evaluate the association between variations in albumin level with HbA1c in the Asian Indian population. Materials and Methods: We screened data of 929 subjects who have had a simultaneous measurement of fasting plasma glucose (FPG), HbA1c and albumin levels via the same blood collection. Data were analyzed by SPSS for 610 subjects who met the study criteria. Results: There was a significant negative correlation between HbA1c and albumin concentration (r = −0.284; P < 0.001). Univariate analysis showed the statistically significant decrease of average HbA1c but not for fasting plasma glucose (FPG) across increasing tertiles of albumin. Stepwise multiple regression model showed a significant correlation between HbA1c and serum albumin (P < 0.05), FPG (P < 0.001), hemoglobin (Hb) (P < 0.001) and serum globulin (P < 0.05). FPG was the strongest predictor (63.4%) of variation of HbA1c. The albumin concentration (r = −0.114) accounted for 0.3% (P < 0.05) of the total variance in HbA1c independent of age, body mass index, FPG, Hb, creatinine, total protein and globulin. It was also observed that HbA1c decreases with increasing albumin concentration in those having FPG between 100 to <126 mg/dl. Conclusion: Serum albumin negatively correlates with HbA1c in Asian Indians independent of other variables. This study suggests that predicting diabetes and its complication based on the HbA1c needs to be further investigated in Indian subjects.


Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2011

Sepsis in diabetes: A bad duo

Shalbha Tiwari; D. Devi Pratyush; Ankur Gahlot; Surya Kumar Singh

Increasing incidence of morbidity and mortality of diabetic subjects due to infection necessitates the understanding of its patho-biology and further remedial measures for its prevention and treatment. The increased incidence of infection is because of systemic illness that has compromising effects on multiple organs including the nervous, vascular, musculoskeletal, and immunologic systems of the diabetic patients. Many factors contribute to this condition including hyperglycemia, insulin deficiency, ischemia and impaired immunity. Sepsis, as a separate entity, lead to destruction of cytokine network that can be fatal. Compromised defense mechanisms due to sepsis and cytokine dysregulation in diabetic patients make the situation worse. Early identification of local infection by applying advanced molecular tools, appropriate selection of antibiotics, intensive wound management, control of glycemic status and supportive treatment can reduce the rate of morbidity and mortality due to sepsis in patients with diabetes.


Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2017

Parenteral vitamin D supplementation is superior to oral in vitamin D insufficient patients with type 2 diabetes mellitus

Awanindra Dwivedi; Balram Gupta; Shalbha Tiwari; Daliparthy D. Pratyush; Saurabh Singh; Surya Kumar Singh

BACKGROUND/OBJECTIVES Oral vitamin D supplementation is better than parenteral in improving vitamin D deficiency in individuals with no systemic illness. Our aim was to compare the efficacy of oral and parenteral routes of vitamin D supplementation on circulating serum 25(OH) vitamin D level in patients with type 2 diabetes mellitus. METHODS Total 85 cases of with type 2 diabetes mellitus were screened for vitamin D status of which 71 patients were vitamin D insufficient/deficient. They were randomized into two intent to treat groups with different vitamin D supplementation protocols (a) Oral-60000 IU per day for 5days (group I; n=40) and (b) injectable-300000 IU intramuscularly once (group II; n=31). Baseline and one month post supplementation 25(OH) vitamin D levels were measured in both the groups. RESULTS Baseline clinical characteristics and 25(OH) vitamin D levels were comparable in both the groups. Post treatment 25(OH) vitamin D level in group I was 26.06±9.06ng/ml and in group II was 49.69±18.92ng/ml. After one month of vitamin D supplementation, increment in 25(OH) vitamin D level from baseline was significantly higher in group II than group I (p<0.001). INTERPRETATION & CONCLUSIONS Injectable method of supplementation was better than oral route in improving serum 25 (OH) vitamin D status in patients with type 2 diabetes. The study suggested impaired absorption of vitamin D from the gastrointestinal tract in patients with type 2 diabetes mellitus and a need for parenteral route of vitamin D supplementation in deficient patients with type 2 diabetes mellitus.


Journal of Diabetes | 2016

Design, implementation and results of a mobile clinic-based diabetes screening program from India

Prasanna B Dhore; Shalbha Tiwari; Mrinal K Mandal; Vedavati B Purandare; Mehmood G Sayyad; Daliparthy D. Pratyush; Ambika Gopalakrishnan Unnikrishnan

Highlights 1. This study describes the implementation of a mobile‐clinic based hub and spoke model to bring diabetes screening and awareness to remote regions. 2. Government‐accredited field workers were trained to conduct high risk screening via house to house visits. 3. The results suggest that this program is effective in bringing diabetes screening and awareness to remote and rural communities.


Microbiology for Surgical Infections#R##N#Diagnosis, Prognosis and Treatment | 2014

Significance of Surgical Intervention in the Management of Diabetic Foot Infections

Shalbha Tiwari; Daliparthy D. Pratyush; Sanjeev Kumar Gupta; Surya Kumar Singh

The incidence of diabetes is increasing at an alarming rate. Diabetic foot is a major cause of frequent hospital visits and extended stays. Both micro and macro-vascular abnormality play a role in its pathogenesis; i.e., it can be neuropathic or ischemic. Other factors such as impaired immunity, poor tissue reparative process and altered foot anatomy further deteriorate wound condition. Infection complicates the wound, delays healing and is a major cause of amputations. Infection control is the primary target for effective wound healing. This can be achieved by appropriate antibiotic selection and surgical intervention. Incision, drainage, debridement, revascularization and wound closure are the key surgical procedures for the management of diabetic foot infection. Careful evaluation of clinical and laboratory findings helps to determine the associated risk of organ involvement, complexity of the wound and severity of infection, as well as the timing of surgical interventions. This chapter provides an overview of diabetic foot infection and its management, with emphasis on surgical intervention.

Collaboration


Dive into the Shalbha Tiwari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Surya Kumar Singh

Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Saurabh Singh

Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Awanindra Dwivedi

Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Sanjeev Kumar Gupta

Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Ambika Gopalakrishnan Unnikrishnan

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

Balram Gupta

Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Mahesh J. Kulkarni

Council of Scientific and Industrial Research

View shared research outputs
Top Co-Authors

Avatar

A. N. Rao

Defence Research and Development Establishment

View shared research outputs
Top Co-Authors

Avatar

A. P. Dash

National Institute of Malaria Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge